Zobrazeno 1 - 10
of 404
pro vyhledávání: '"Heinz, Höfler"'
Autor:
Emanuel F. Petricoin, Karl-Friedrich Becker, Lance A. Liotta, Laura Esserman, Heinz Höfler, Christine Waldhör, Ingrid Becker, Holger Bronger, Axel Walch, Angela DeMichele, Jianghong Deng, Mariaelena Pierobon, Virginia Espina, Julie Illi, Kai Tran, Rupert Langer, Claudia Wolff, Daniela Berg, Julia D. Wulfkuhle
PDF file - 103K, Validation of the reproducibility of the RPMA for HER2 and pHER2 analysis from FFPE-tissues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41d853a401d95d9f4898c98d8a80f49a
https://doi.org/10.1158/1078-0432.22455048.v1
https://doi.org/10.1158/1078-0432.22455048.v1
Autor:
Emanuel F. Petricoin, Karl-Friedrich Becker, Lance A. Liotta, Laura Esserman, Heinz Höfler, Christine Waldhör, Ingrid Becker, Holger Bronger, Axel Walch, Angela DeMichele, Jianghong Deng, Mariaelena Pierobon, Virginia Espina, Julie Illi, Kai Tran, Rupert Langer, Claudia Wolff, Daniela Berg, Julia D. Wulfkuhle
PDF file - 54K, Antibodies used for Array and Western Blot Immunostaining
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19b9e06539f3d7897137eb4de24586f2
https://doi.org/10.1158/1078-0432.22455045
https://doi.org/10.1158/1078-0432.22455045
Autor:
Emanuel F. Petricoin, Karl-Friedrich Becker, Lance A. Liotta, Laura Esserman, Heinz Höfler, Christine Waldhör, Ingrid Becker, Holger Bronger, Axel Walch, Angela DeMichele, Jianghong Deng, Mariaelena Pierobon, Virginia Espina, Julie Illi, Kai Tran, Rupert Langer, Claudia Wolff, Daniela Berg, Julia D. Wulfkuhle
Purpose: Targeting of the HER2 protein in human breast cancer represents a major advance in oncology but relies on measurements of total HER2 protein and not HER2 signaling network activation. We used reverse-phase protein microarrays (RPMA) to measu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74eb76a7f082cafd899f2f8f29cfd9f1
https://doi.org/10.1158/1078-0432.c.6522909
https://doi.org/10.1158/1078-0432.c.6522909
Autor:
John A. Foekens, Sabine Maier, Manfred Schmitt, Jan G.M. Klijn, Marion Kiechle, Heinz Höfler, Alexander Olek, Christian Piepenbrock, Marion E. Meijer-Van Gelder, Henk Portengen, Anieta M. Sieuwerts, Joan Bolt-de Vries, Antje Kluth, Fabian Model, Nadia Harbeck, Maxime P. Look, Thomas Koenig, Inko Nimmrich, John W.M. Martens
Supplementary Table S1 from Association of DNA Methylation of Phosphoserine Aminotransferase with Response to Endocrine Therapy in Patients with Recurrent Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aaff26e2cb3f79b95d6aca016611b1f
https://doi.org/10.1158/0008-5472.22363230
https://doi.org/10.1158/0008-5472.22363230
Autor:
Birgit Luber, Heinz Höfler, Claus Hann von Weyhern, Rupert Langer, Sandra Rauser, Karl-Friedrich Becker, Christine Hermannstädter, Gisela Keller, Justus Duyster, Jörg Mages, Margit Fuchs, Axel Walch, Anja Bremm
Mutations of the tumor suppressor E-cadherin and overexpression of the receptor tyrosine kinase epidermal growth factor receptor (EGFR) are among the most frequent genetic alterations associated with diffuse-type gastric carcinoma. Accumulating evide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe196a58ac9f6a17004403f5e5b561d
https://doi.org/10.1158/0008-5472.c.6497694
https://doi.org/10.1158/0008-5472.c.6497694
Autor:
Birgit Luber, Heinz Höfler, Claus Hann von Weyhern, Rupert Langer, Sandra Rauser, Karl-Friedrich Becker, Christine Hermannstädter, Gisela Keller, Justus Duyster, Jörg Mages, Margit Fuchs, Axel Walch, Anja Bremm
Supplementary Tables S1-S3 from Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2831a1674cb228039d2380dd78da2f2
https://doi.org/10.1158/0008-5472.22375053.v1
https://doi.org/10.1158/0008-5472.22375053.v1
Autor:
John A. Foekens, Sabine Maier, Manfred Schmitt, Jan G.M. Klijn, Marion Kiechle, Heinz Höfler, Alexander Olek, Christian Piepenbrock, Marion E. Meijer-Van Gelder, Henk Portengen, Anieta M. Sieuwerts, Joan Bolt-de Vries, Antje Kluth, Fabian Model, Nadia Harbeck, Maxime P. Look, Thomas Koenig, Inko Nimmrich, John W.M. Martens
To understand the biological basis of resistance to endocrine therapy is of utmost importance in patients with steroid hormone receptor–positive breast cancer. Not only will this allow us prediction of therapy success, it may also lead to novel the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f243044ba04d42db682bb035abd8451
https://doi.org/10.1158/0008-5472.c.6493611.v1
https://doi.org/10.1158/0008-5472.c.6493611.v1
Autor:
Birgit Luber, Heinz Höfler, Claus Hann von Weyhern, Rupert Langer, Sandra Rauser, Karl-Friedrich Becker, Christine Hermannstädter, Gisela Keller, Justus Duyster, Jörg Mages, Margit Fuchs, Axel Walch, Anja Bremm
Supplementary Results, Figure 1, Methods and Materials from Enhanced Activation of Epidermal Growth Factor Receptor Caused by Tumor-Derived E-Cadherin Mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691af4e0fc257797b18be9fe98538f57
https://doi.org/10.1158/0008-5472.22375056
https://doi.org/10.1158/0008-5472.22375056
Autor:
Johannes Ettl, Evelyn Klein, Alexander Hapfelmeier, Kirsten Grosse Lackmann, Stefan Paepke, Christoph Petry, Katja Specht, Laura Wolff, Heinz Höfler, Marion Kiechle
Publikováno v:
PLoS ONE, Vol 12, Iss 9, p e0183917 (2017)
Adjuvant therapy decisions in early breast cancer are based on accurate risk assessment. Urokinase plasminogen activator (uPA) and plaminogen activator inhibitor-1 (PAI-1) have been the first biomarkers in hormone receptor (HR) positive breast cancer
Externí odkaz:
https://doaj.org/article/1cfcd76762d748f7931d037067051174
Publikováno v:
Image Analysis and Stereology, Vol 19, Iss 1, Pp 39-43 (2011)
One of the most important questions in clinical routine is to find out patients with good or worse prognosis to apply an optimal therapy scheme for each patient. In this study 58 patients with different neuroendocrine tumours of the lung were investi
Externí odkaz:
https://doaj.org/article/3a1dac2b34a447fab20dd1059517625d